Every record from Janoshik · page 14
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043444 | Semaglutide | WXT | WXT-2512-F4804 | 2026-Q2 | 99.20 | 4.67 | 91.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043247 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.31 | 4.52 | 101.0 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043005 | Tirzepatide | KP | KP-2602-X5446 | 2026-Q2 | 98.87 | 6.31 | 96.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042851 | Retatrutide | GGPeps | GGPE-2511-X1688 | 2026-Q2 | 98.19 | 4.93 | 96.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042755 | TB-500 | GGPeps | GGPE-2601-B9932 | 2026-Q2 | 99.54 | 4.67 | 94.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042331 | Tirzepatide | HJ | HJ-2605-D3120 | 2026-Q2 | 98.36 | 3.95 | 93.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041851 | ARA-290 | JEEP | JEEP-2601-K3139 | 2026-Q2 | 99.00 | 4.51 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041530 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.93 | 2.38 | 106.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043522 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | 2026-Q2 | 98.13 | 4.21 | 96.8 | Supplier-supplied | 1 | FAIL |
| AX-2026-043301 | IGF-1 LR3 | CPC | CPC-2512-S2394 | 2026-Q2 | 97.55 | 2.33 | 104.5 | Laboratory-retained | 0 | PASS |
| AX-2026-043139 | Tirzepatide | SSA | SSA-2511-N7115 | 2026-Q2 | 97.61 | 5.74 | 104.7 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042436 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 97.68 | 4.32 | 95.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043154 | MOTS-c | SSA | SSA-2511-W7415 | 2026-Q2 | 97.76 | 6.00 | 92.3 | Supplier-supplied | 0 | FAIL |
| AX-2026-043114 | Mazdutide | SSA | SSA-2605-G6781 | 2026-Q2 | 99.02 | 3.41 | 101.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043051 | Hexarelin | KP | KP-2604-X5435 | 2026-Q2 | 99.10 | 3.16 | 104.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042869 | BPC-157 | GGPeps | GGPE-2512-G2285 | 2026-Q2 | 97.95 | 3.48 | 93.8 | Supplier-supplied | 2 | FAIL |
| AX-2026-042702 | Semaglutide | GGPeps | GGPE-2604-L9412 | 2026-Q2 | 98.39 | 5.85 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042640 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | 2026-Q2 | 97.46 | 1.89 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043449 | BPC-157 | WXT | WXT-2602-W4680 | 2026-Q2 | 98.12 | 5.60 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043002 | Tirzepatide | KP | KP-2602-X5446 | 2026-Q2 | 98.60 | 6.37 | 100.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042965 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.15 | 5.64 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042712 | BPC-157 | GGPeps | GGPE-2511-S9531 | 2026-Q2 | 98.68 | 2.48 | 92.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042335 | L-Glutathione (reduced) | HJ | HJ-2511-F3082 | 2026-Q2 | 99.93 | 6.47 | — | Laboratory-retained | 0 | PASS |
| AX-2026-042284 | Semaglutide | Homopeptide | HOMO-2604-M2254 | 2026-Q2 | 99.51 | 2.48 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041707 | Hexarelin | QSC | QSC-2601-N9656 | 2026-Q2 | 99.74 | 5.68 | 104.8 | Supplier-supplied | 1 | FAIL |
| AX-2026-041445 | Liraglutide | QYB | QYB-2511-V5143 | 2026-Q2 | 98.58 | 5.78 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041436 | BPC-157 | QYB | QYB-2601-D4733 | 2026-Q2 | 99.85 | 3.95 | 89.9 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-042853 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 98.62 | 3.78 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042848 | Retatrutide | GGPeps | GGPE-2511-X1688 | 2026-Q2 | 98.64 | 5.38 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041621 | BPC-157 | QSC | QSC-2511-N8732 | 2026-Q2 | 99.93 | 5.60 | 96.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041532 | BPC-157 | QYB | QYB-2601-H6381 | 2026-Q2 | 99.93 | 2.43 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041435 | BPC-157 | QYB | QYB-2601-D4733 | 2026-Q2 | 99.93 | 3.77 | 96.6 | Supplier-supplied | 0 | PASS |
| AX-2026-041226 | Thymulin | WWB | WWB-2602-S2129 | 2026-Q2 | 99.36 | 4.19 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043532 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2511-G7276 | 2026-Q2 | 98.18 | 4.32 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-042940 | CJC-1295 (no DAC) | MKM | MKM-2512-Y3111 | 2026-Q2 | 97.49 | 4.60 | 106.5 | Supplier-supplied | 2 | FAIL |
| AX-2026-042787 | Selank | GGPeps | GGPE-2601-J1391 | 2026-Q2 | 99.37 | 9.27 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042695 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.19 | 3.76 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042653 | Semax | GGPeps | GGPE-2602-Y8213 | 2026-Q2 | 99.09 | 5.66 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042455 | NAD+ | SWB | SWB-2602-P5992 | 2026-Q2 | 99.22 | 10.60 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042158 | GHRP-2 | Homopeptide | HOMO-2602-E9033 | 2026-Q2 | 99.59 | 4.35 | 89.8 | Buyer-sourced | 2 | MARGINAL |